2024 perioperative management glp-1 receptor agonists anesthesia Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 How should we approach patients

Gramer, Gwendolyn et al

Thats up from 8% in 2025 and 3% in 2024, according to the polling firm

Finally, GSH deficiency contributes to oxidative/nitrosative stress, a condition actually connected with the pathogenesis of many diseases, including cancer, diseases of aging, cystic fibrosis, infection and neurodegeneration

Option 1: Discard and mix fresh Cost: Price of new vial Benefit: Guaranteed full potency Risk: None (besides cost) Option 2: Continue using Cost: None (already paid for) Benefit: Don't waste remaining peptide Risk: 10-15% potency loss means 10-15% less effectiveness Calculation: If vial costs $50 and you're at day 35 with half remaining, you're deciding whether to waste $25 to guarantee full potency, or accept 10-15% reduced effectiveness